The presence of behaviorally defined sleep-like states in such a diverse array of creatures, even in animals as simple as
C. elegans, raises the question of whether sleep evolved independently in each of these animals or whether sleep was present in a primitive form in the common ancestor of worms, flies, fish, and even humans. While studies of the genetics and pharmacology of sleep are still in their infancy, particularly for the genetic model species, the remarkable similarity in the genetic and pharmacological control of sleep provides compelling support for the latter hypothesis. This suggests that sleep was present in the common ancestor of all bilaterally symmetric organisms over 600 million years ago. Indeed, even the cnidarian jellyfish, which represents an even more ancient branch of the animal kingdom, has been reported to show sleep-like states [
99,
100]. We shall focus on genes with functions that affect sleep, discussing three areas of conservation: circadian clock genes, signaling pathways, and neurotransmission. There are many excellent gene expression profiling studies [
22–
25,
87,
101,
102] that also suggest conservation of sleep mechanism but we do not have space to discuss them here.
One of the most well conserved pathways for sleep regulation is the circadian clock, or more precisely, the circadian clock genes (). Circadian clocks are composed of transcriptional feedback loops that are highly conserved between flies and mammals. In
Drosophila, the CLOCK (CLK) transcription factor along with its heterodimeric partner CYCLE (CYC), activates the
period (
per) and
timeless (tim) genes (reviewed in [
103]). The PER and TIM proteins feedback and repress CLK/CYC. PER and TIM are also modified by phosphorylation by kinases such as DOUBLETIME (DBT), leading to their degradation and allowing the cycle to proceed. Remarkably, mutations in the human orthologs of the
per and
Dbt genes have been shown to be responsible for familial advanced sleep phase syndrome [
104,
105]. Individuals affected with this dominantly inherited syndrome sleep and wake 3–4 hours before their unaffected siblings [
106]. Not surprisingly, zebrafish uses similar genes to those identified in flies and mammals to regulate its circadian clocks [
75,
107]. As mentioned above, in
C. elegans lethargus is also linked to the oscillation of its
per gene,
lin-42, but this oscillation is controlled by a developmental, not a circadian clock. Taken together, these observations suggest that sleep is linked to oscillation of ‘clock’ genes, and that this may even have preceded the evolution of fully-fledged circadian clocks, at least in animals. At least some unicellular organisms show circadian or ultradian rhythms [
108,
109], but evidence for sleep in unicellular organisms is lacking (see below).
Interestingly, disruption of clock function can affect not only the timing of sleep but also the amount of sleep. Lesion of the mammalian circadian pacemaker, the suprachiasmatic nucleus (SCN), can increase sleep time in some primates [
110] and in mice [
111] (although not in rats) [
112]. Nonetheless, mutations of the
Clock gene not only disrupt circadian aspects of sleep but also result in reduced sleep in both flies [
113] and mice [
114]. Mutations of the heterodimeric partner of CLK, CYC, also result in reduced sleep levels [
4,
113]: male
cyc mutant flies display reduced sleep rebound [
113] and female
cyc mutant flies are hypersensitive to the lethal effects of sleep deprivation [
4]. Knockouts of the mouse CYC ortholog, Bmal1, actually exhibit an increase in sleep time [
115]; however, they display reduced sleep rebound similar to male flies [
115].
A number of signal transduction pathways also appear to be commonly deployed in the regulation of sleep (). The cyclicAMP(cAMP) pathway, including the cAMP-dependent protein kinase A and cAMP activated transcription factor CREB, plays a role in promoting wakefulness in worms, flies, and mice. In
Drosophila, a series of mutations in cAMP pathway components or overexpression of components that would increase cAMP levels or activity of downstream components, increases wake behavior, whereas mutations that result in the converse increase sleep [
116,
117]. Similarly, in
C. elegans, mutations that increase cAMP lead to increase responsiveness to sensory stimuli [
94]. In mice, knockout of two CREB isoforms results in reduced wakefulness [
118]. Interestingly, this pathway has been implicated as a central player in long term memory formation in both flies and mice, suggesting potential genetic links between sleep regulation and memory consolidation [
119]. Consistent with this hypothesis, a key neural locus for learning and memory, the mushroom bodies, is also an important neural substrate for sleep regulation [
117,
120].
Cyclic GMP signaling may also play a conserved role in sleep regulation. Gain- and loss-of-function mutants in
egl-4, which encodes the worm ortholog of cGMP-dependent protein kinase (PKG), result in increased and decreased behavioral quiescence, respectively [
94]. Similarly, a mutation in the
Drosophila PKG
foraging (
for) locus, which lowers PKG activity, is associated with reduced sleep, suggesting potential conservation of sleep mechanisms between flies and worms [
94].
A third signaling pathway that is conserved for sleep control is that of the epidermal growth factor receptor (EGF receptor), with increases in EGF resulting in increased sleep/quiescence, while reductions in EGF receptor signaling result in increased wake/activity. Remarkably, the EGF receptor has been shown to control sleep behavior in worms, flies, and mice (). The EGF receptor is a transmembrane receptor tyrosine kinase that is activated by secreted growth factor ligands such as EGF and transforming growth factor-alpha (TGFα). EGF infusion enhances slow-wave sleep in rabbits [
121]. The EGF receptor ligand, TGFα, is rhythmically expressed and secreted by the mammalian SCN [
122]. TGFα infusion into the third ventricle substantially inhibited wheel-running activity while loss of function EGF receptor mutants exhibited increased daytime activity [
122], although effects on light induced behavior have been questioned [
123]. In flies, induction of EGF ligand secretion by overexpression of EGF processing proteins, Rho and Star, results in increased sleep, while targeted
rho loss of function by RNA interference (RNAi) results in reduced sleep [
124]. In worms, transient induction of
Egf (
lin-3) expression results in behavioral quiescence even in adult animals, while
egfr (
let-23) loss-of-function mutations result in increased activity during lethargus periods [
125]. The remarkable conservation of EGF signaling across evolution suggests it is a component of an ancient sleep pathway.
Sleep is largely regarded as a neurally driven phenomenon and a number of neurotransmitters appear to play conserved roles in sleep (). We will comment only on the system-level effect of manipulation of gene/neurotransmitter function and compare the effects between organisms. More precise manipulations particularly in mammalian systems suggest more complex regulatory functions within discrete circuits.
The most commonly used drugs that induce sleep and treat sleep disorders function by activating GABA receptors. GABAergic compounds such as benzodiazepines and barbiturates also induce sleep in fish as they do in ‘higher’ organisms [
77,
126]. In
Drosophila, GABA receptor mutants that reduce desensitization of the GABA receptor (resulting in maintained GABA signaling) fall asleep more quickly (show reduced sleep latency) [
127]; elegant genetic analyses revealed that these GABA receptor mutants block desensitization and sleep latency increases induced by drugs [
127].
One issue that has arisen is the precise role of the hypocretin/orexin system in zebrafish. Loss of hypocretin cells, or mutations in the hypocretin receptors and ligands, results in the sleep disorder narcolepsy in both humans and mice [
128–
133]. Narcolepsy is characterized by persistent sleepiness, rapid transitions from wake directly to REM sleep and sudden losses of muscle tone (cataplexy) [
131,
134,
135]. The hypocretin/orexin system plays a pivotal role in maintaining the wakeful state [
135]. Expression of a heat-shock inducible form of hypocretin/orexin in larval zebrafish disrupted sleep, supporting the view that hypocretin/orexin has a wake-promoting role [
73]. Similarly, injection of hypocretin/orexin peptide into the brains of adult goldfish increased locomotor activity [
136]. But adult fish bearing loss-of-function alleles of the single hypocretin/orexin receptor displayed modestly reduced sleep time with increased sleep fragmentation [
78]. Furthermore, some anatomical studies suggested that the hypocretin/orexin receptor is expressed in different circuits in adult fish than in mammalian models, while others have suggested that the hypocretin/orexin circuit architecture is preserved [
73,
78,
137]. The differences between the results of the two genetic studies may be attributed to many factors, including assessment at different developmental stages (larval versus adult) with potentially different neural circuitries, use of inducible versus non-inducible genetic manipulations with their potential of developmental and/or compensatory changes, gain-of-function with potentially ectopic effects versus loss-of-function approaches, and manipulation of ligand versus receptor genes. Nonetheless, these studies highlight a role for hypocretin/orexin in sleep in zebrafish, the precise nature of which awaits additional experimentation. Hypocretin/orexin has not been identified in invertebrates.
In many animals, melatonin is secreted at night and induces sleep in diurnal animals, including humans [
138–
141]. Zebrafish also rhythmically produces melatonin [
142] and melatonin also induces sleep —in particular, changes in the activity and arousal threshold — in zebrafish [
77]. The sleep inducing effects of melatonin have not been described in invertebrates.
A variety of other transmitters also may play conserved roles between flies and mammals. The ATP breakdown product adenosine increases in response to wakefulness and can, in turn, induce sleep by acting through specific G-protein coupled receptors [
143]. Caffeine is thought to act as an adenosine receptor antagonist. In
Drosophila, caffeine induces wakefulness, while the adenosine agonist cyclohexyladenosine induces sleep [
86,
87]. Antihistamines are also noted to induce sleep in mammals [
144]. Similarly, antihistamines can induce sleep in both
Drosophila [
87] and zebrafish [
126]. Drugs or mutants that enhance or inhibit dopaminergic transmission and activity result in reduced and increased sleep in
Drosophila [
145,
146], as they do in mammals. Even the novel wake-promoting agent modafinil, which is thought to act via dopaminergic pathways [
147], similarly promotes wakefulness in flies [
148]. Conservation also extends to the potassium channel family [
149,
150].